Glaukos Corporation (6GJ)
FSX
Real-time Data
06:00 AM
Day's Range
157.0052 wk Range
63.50Overview - 6GJ - Glaukos Corporation
Key Statistics
Valuation
Enterprise Value
7.72B
P/E (Trailing)
‪-47.86‬
P/E (Forward)
‪-109.09‬
PEG Ratio
‪5.42‬
Price / Sales (TTM)
‪15.01‬
Price / Book
‪15.70‬
EV / EBITDA
‪-243.57‬
Profitability
Gross Margin
‪81.67%‬
Profit Margin
‪-30.68%‬
Operating Margin
‪-8.49%‬
Return on Assets
‪-5.17%‬
Return on Equity
‪-25.98%‬
Ownership
Shares Outstanding
58.85M
Float
56.81M
Held by Insiders
‪3.60%‬
Held by Institutions
‪105.45%‬
Price stats
Beta
‪0.76‬
50-Day Avg
‪134.76‬
200-Day Avg
‪106.85‬
Dividends
Payout Ratio
‪0.00%‬
Peers - 6GJ - Glaukos Corporation
Peer Comparison
Compared with companies in Medical Devices listed on FSX.
Profile Summary - 6GJ - Glaukos Corporation
About
Glaukos Corporation is a medical technology company dedicated to the development and commercialization of innovative products for the treatment of glaucoma, corneal disorders, and retinal diseases. Its primary function is to address the substantial unmet medical needs present in ophthalmic healthcare. Glaukos is…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
